2015 annual financial data
Anika Therapeutics 2015 Operating margin
Anika Therapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was 51.76%.
Operating income was 48,134,000 USD and net income was 30,758,000 USD.
Operating cash flow was 39,064,000 USD.
Get free Anika Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 92,999,000 USD
- Operating income
- 48,134,000 USD
- Net income
- 30,758,000 USD
- Operating cash flow
- 39,064,000 USD